Saad J. Kenderian

Dr. Saad J. Kenderian, a hematology consultant at the Mayo Clinic, discusses the revolutionary CAR-T cell therapy, which modifies T-cells to target blood cancers like leukemia. He emphasizes patient selection and treatment monitoring, while exploring the therapy's potential for autoimmune diseases. The conversation delves into cytokine storms, linking lessons from COVID-19 to cancer treatment challenges. Additionally, Kenderian addresses the need for increased awareness about CAR-T therapy and its accessibility hurdles, highlighting its transformative potential for many patients.